Skip to content

Clinical trials

Phase 2/3 Opioid-Related Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Opioid-Related Disorders Phase: Phase 2/3 Country / region: United States Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20092
20101
20111
20141
20162
20172
20182
20191
20202
20212
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting3
Terminated2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
New York State Psychiatric Institute8
University of Pennsylvania3
Friends Research Institute, Inc.2
Gavin Bart1
Johns Hopkins University1
Lifespan1
Massachusetts General Hospital1
Oregon Health and Science University1
Rhode Island Hospital1
University of California, Los Angeles1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Opioid-Related Disorders25
Heroin Dependence3
Substance-Related Disorders3
Cocaine-Related Disorders2
Acquired Immunodeficiency Syndrome1
Attention Deficit Disorder with Hyperactivity1
Chronic Pain1
Lymphoma, Follicular1
Restless Legs Syndrome1
Sleep Wake Disorders1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.